Testing a new method for measuring allergy-related IgE levels
Official title: Feasibility Study of a New Immunoglobulin E (IgE) Assay Method in Urine and Blood
Run by University Hospital, Toulouse · NCT04751760 · Data updated 2026-11-12
This study is testing a new way to measure allergy-related IgE levels using less blood and faster results to help both kids and adults with allergies get diagnosed and treated more easily.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Months to 99 Years |
| Sex | All |
| Enrollment | 1376 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 2 sites (Toulouse and 1 other locations) |
| Status | Recruiting |
| Started | April 20, 2021 |
| Main results expected | April 20, 2026 |
| Study ends | April 20, 2026 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT04751760 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include males and females aged 6 months and older who have a confirmed allergy or sensitization to specific allergens.
✕Probably not a fit
Patients younger than 6 months, those weighing less than 10 kg, pregnant or breastfeeding women, and individuals with certain autoimmune conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the feasibility of a new specific IgE assay called LuLISA, which utilizes a bioluminescence technique to analyze blood and urine samples from both pediatric and adult patients with allergies. The current standard method, ImmunoCAP, is costly and requires a significant amount of blood, which poses challenges especially for children. By using the LuLISA method, the study seeks to reduce the amount of blood needed and improve the turnaround time for results, potentially allowing for quicker diagnosis and management of allergies. The study will involve collecting samples during routine follow-up visits for allergy patients.
Why it matters
Potential benefit: If successful, this new assay could provide a more efficient and less invasive way to diagnose allergies, leading to better patient management.
How similar studies have gone: While the LuLISA method has shown promise for quantifying IgE against specific allergens, its broader application for other allergens is still being explored, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males or females 6 months' old or older * Sensitization or allergy towards a trophallergen, an aeroallergen, hymenoptera venom or drug proven by: * positive skin test (s) * and / or IgE specific (s)\> 0.1 kUA / L * and / or anamnesis in favor of an allergic reaction of mediated IgE * Social coverage up to date Exclusion Criteria: * Children younger than 6 months'old * Children's weight less than 10 kg * Pregnant or breastfeeding women * Patients with cystic fibrosis * Patients with dysimmune or autoimmune pathology * Anamnesis in favor of a delayed allergy or a contact allergy.
Where it's running
-
University Hospital
Toulouse, France Recruiting -
Larrey hospital
Toulouse, France Recruiting
Study contacts
- Principal investigator: Marine Michelet, MD — University Hospital, Toulouse
- Study coordinator: Marine Michelet, MD
- Email: michelet.m@chu-toulouse.fr
- Phone: 33-5 34 55 85 85
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Shape: Skin health and allergy prevention in infants
A baby-born trial tests a multi-component environmental package to see if it can help prevent food allergies in at-risk infants.
-
Maternal peanut and egg consumption versus avoidance during pregnancy and breastfeeding
This study will test whether mothers eating or avoiding peanuts and eggs from late pregnancy through breastfeeding changes babies' chances of developing peanut or egg allergies.
-
Longitudinal study of Victorian children and their parents
This study is looking at the health and wellbeing of children born in Victoria and their parents over time to see how different factors affect their physical and mental health.
-
Study of human organoids to understand host-microbe interactions
This study is trying to see how the tiny organisms in our gut interact with our body by using samples from people getting endoscopies to grow mini versions of their intestines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.